BE-59-WG31_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, 3-(4-Methyl-1H-imidazol-1-yl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-5-(trifluoromethyl)benzamide, Abl Kinase Inhibitors;Bcr-Abl Kinase Inhibitors;Inhibitors of Signal Transduction Pathways targeting ABL1 (Novartis, 10256418)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10256418
Similar Terms
Downloads & Tools

Genes

17 genes differentially expressed following the BE-59-WG31_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MT2A metallothionein 2A 0.675437
TIMP1 TIMP metallopeptidase inhibitor 1 0.452234
S100A2 S100 calcium binding protein A2 0.265823
TAGLN transgelin 0.256447
KRTAP2-3 keratin associated protein 2-3 0.234771
LSM7 LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) 0.228848
OCIAD2 OCIA domain containing 2 0.223401
LGALS1 lectin, galactoside-binding, soluble, 1 0.205496
ZNF593 zinc finger protein 593 0.204356
LMNA lamin A/C 0.202356
ATOX1 antioxidant 1 copper chaperone 0.200888
NDUFB7 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa 0.200888

decreased expression

Symbol Name Standardized Value
UBE2O ubiquitin-conjugating enzyme E2O -0.238293
C1QTNF12 C1q and TNF related 12 -0.22435
DHRS2 dehydrogenase/reductase (SDR family) member 2 -0.210588
CLPTM1L CLPTM1-like -0.204356
CRYAB crystallin, alpha B -0.200888